Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality Home
BiotechReality – Information Intelligence System for Biopharma
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#Eli Lilly and Company #Johnson&Johnson #Clinical Data #Quarterly Results #FDA Approval #Phase 3 Trials #Novo Nordisk #Cancer

Category: News

Science News

Nobel Prize in Physiology or Medicine 2024 for the discovery of microRNA and its role in post-transcriptional gene regulation

  • By Editor's Desk
  • 8 October 2024
nobel prize in physiology or medicine 2024
nobel prize in physiology or medicine 2024

The discovery of a crucial regulatory mechanism that cells utilize to regulate gene activity is the main focus of this year’s Nobel Prize.

Tagged mRNA, Nobel Prize, Nobel Prize 2024, Nobel Prize for Physiology or Medicine
Cancer News Research

Researchers Decoded Key TET2 Mutations in Cancers

  • By Editor's Desk
  • 6 October 2024
cancer representation

However, it’s also known that TET2 mutations can result in conditions other than cancer. A portion of persons over the age of 70 also had TET2 mutations, which raise the risk of diabetes, heart disease, stroke, and other inflammatory diseases as well as CHIP.

Tagged Cancer, Cancer Mutations, Mutation
Neuroscience News Research

Deep brain stimulation shows rapid improvement in arm and hand strength after brain injury or stroke

  • By Editor's Desk
  • 3 October 2024
deep brain stimulation

Brain lesions produced by major brain trauma or stroke can alter neuronal connections between the motor cortex, a critical brain area needed for coordinating voluntary movement, and the muscles.

Tagged Deep Brain Stimulation
Microbiology News Research

Researchers found the impact on hormone levels in mice by gut microbiome

  • By Journal Updates
  • 30 September 2024
gut microbiome and hormones

The mix of microorganisms in the stomach can affect the symptoms of hypopituitarism in mice, according to research from the Francis Crick Institute. Additionally, they [Read More…]

Tagged Gut Bacteria, Hormone Levels, microbiome
Gene Therapy Clinical Trials News

Phase III Clinical Trials Shows Promising Results for Gene Therapy Against Hemophilia B

  • By Editor's Desk
  • 27 September 2024
hemophilia gene therapy

The outcomes of an international Phase III clinical trial conducted by researchers from the University of Pennsylvania Perelman School of Medicine and a multicenter group [Read More…]

Tagged Hemophilia
Bioinformatics Microbiology News

Researchers found antibiotic-resistant bacteria using bioinformatics tools

  • By Journal Updates
  • 24 September 2024
antibiotic resistant bacteria

When penicillin was discovered, it was heralded as “the silver bullet” because of its extraordinary ability to eradicate germs that cause illness without endangering humans. [Read More…]

Tagged antibiotic resistance
Cell Biology News Research

Fever enhances the mitochondrial damage in immune cells

  • By Journal Updates
  • 21 September 2024
mitochondria cells

Researchers at Vanderbilt University Medical Centre have shown that while fever raises immune cell metabolism, proliferation, and activity, it also causes mitochondrial stress, DNA damage, [Read More…]

Tagged Immune System, mitochondria
Neuroscience News Research

Genetic risk-factor overlap between Alzheimer’s disease and vascular dementias

  • By Editor's Desk
  • 19 September 2024
Genetic risk-factor overlap between Alzheimer's disease and vascular dementias

The report states that vascular dementia is the second most frequent subtype of dementia after Alzheimer’s disease. Still, the two illnesses are different clinically.

Tagged Alzheimer's, Vascular Dementia
Clinical Trials News Research

New Vaccine Developed for Lassa Fever; ready for Phase 1 Trials

  • By Journal Updates
  • 13 September 2024
vaccine vial image

A novel vaccine candidate that offers protection against Lassa fever has been developed by researchers from Thomas Jefferson University and the University of Maryland Baltimore, [Read More…]

Tagged Lassa Fever, Vaccine Development
Gene Therapy Clinical Trials News

Patients with a rare inherited eye disease shows improvement after Gene Therapy Trials

  • By Editor's Desk
  • 9 September 2024
gene therapy clinical trials

A Phase 1/2 trial included 15 individuals in total, among them three pediatric patients. The patients all suffered from the disease Leber congenital amaurosis caused by a gene that is essential in making proteins crucial to vision.

Tagged Eye Disease, Gene Editing

Posts navigation

← Older Posts
→ Newer Posts
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biosimilars
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • CDMO
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRDMO
  • CRO
  • Cybersecurity
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Merger & Acquisitions
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

Merck KGaA Q3 2026 Results: Pimjetmi FDA Approval and Silence Therapeutics Deal Back a Raised Full-Year Outlook
Business Life Sciences News

Merck KGaA Q3 2026 Results: Pimjetmi FDA Approval and Silence Therapeutics Deal Back a Raised Full-Year Outlook

12 November 202612 November 2026
BiotechReality Business Intelligence Desk
Novartis Rhapsido CIndU Data: Remibrutinib Shows Sustained Efficacy Through Week 52 in Phase III RemIND Study
Clinical Data Healthcare & Pharmaceuticals News

Novartis Rhapsido CIndU Data: Remibrutinib Shows Sustained Efficacy Through Week 52 in Phase III RemIND Study

12 November 202612 November 2026
Clinical Trials & Data Desk
Amgen Dazodalibep Phase 3 OASIZ-301 Results Show Systemic Disease Activity Gains in Sjögren’s Disease
Clinical Data Healthcare & Pharmaceuticals News Rare Diseases

Amgen Dazodalibep Phase 3 OASIZ-301 Results Show Systemic Disease Activity Gains in Sjögren’s Disease

12 November 202612 November 2026
Clinical Trials & Data Desk
Novo Nordisk World Diabetes Foundation Commitment: Pledges USD 200 Million for Diabetes Prevention and Care, 2027–2036
Diabetes Business Healthcare & Pharmaceuticals News

Novo Nordisk World Diabetes Foundation Commitment: Pledges USD 200 Million for Diabetes Prevention and Care, 2027–2036

11 November 202611 November 2026
BiotechReality Business Intelligence Desk
Charles River Frontage Acquisition: Charles River Laboratories to Buy Frontage’s Bioanalysis and DMPK Businesses for About $470 Million
Merger & Acquisitions Healthcare & Pharmaceuticals News

Charles River Frontage Acquisition: Charles River Laboratories to Buy Frontage’s Bioanalysis and DMPK Businesses for About $470 Million

9 November 20269 November 2026
BiotechReality Business Intelligence Desk
Eli Lilly and Company’s Foundayo Sleep Apnea Phase 3 ATTAIN-OSA Results Show Up to 44% Fewer Breathing Interruptions
Clinical Data Clinical Trials Healthcare & Pharmaceuticals News Weight-loss Drugs

Eli Lilly and Company’s Foundayo Sleep Apnea Phase 3 ATTAIN-OSA Results Show Up to 44% Fewer Breathing Interruptions

9 November 20269 November 2026
Clinical Trials & Data Desk
Advertisement
BiotechReality JobFinder

  • Global Clinical Supply Business Support Coordinator – Pfizer, Makati
    9 November 2026
  • Senior Product Analyst – Novartis, India
    25 October 2026
  • Rare Disease Medical Science Liaison (MSL) – Amgen, Japan
    20 October 2026
  • Clinical Project Management Director – IQVIA
    16 October 2026
  • Senior Manager, Global Digital Marketing – Lonza
    11 October 2026

BiotechReality Shots Weekly Newsletter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter